Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase II Study of Treatment De-Escalation for Favorable Prognosis, Stage I-II Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

The current standard treatment option for Human Papillomavirus (HPV) or p16-positive oropharyngeal cancer is full-dose radiation combined with chemotherapy. Re…

Oropharyngeal CancersHPVTonsil Cancer+1 more

Georgetown UniversityNCT06902623